Details
Stereochemistry | ACHIRAL |
Molecular Formula | C13H8Cl2O2.2Na |
Molecular Weight | 313.087 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].[Na+].[O-]C1=CC=C(Cl)C=C1CC2=C([O-])C=CC(Cl)=C2
InChI
InChIKey=IDPAELWVMULBFJ-UHFFFAOYSA-L
InChI=1S/C13H10Cl2O2.2Na/c14-10-1-3-12(16)8(6-10)5-9-7-11(15)2-4-13(9)17;;/h1-4,6-7,16-17H,5H2;;/q;2*+1/p-2
DescriptionSources: http://www.ncbi.nlm.nih.gov/pubmed/9168328Curator's Comment: Description was created based on several sources, including http://www.ncbi.nlm.nih.gov/pubmed/15162836 and http://datasheets.scbt.com/sc-255083.pdf
Sources: http://www.ncbi.nlm.nih.gov/pubmed/9168328
Curator's Comment: Description was created based on several sources, including http://www.ncbi.nlm.nih.gov/pubmed/15162836 and http://datasheets.scbt.com/sc-255083.pdf
Dichlorophene is a halogenated phenolic compound that functions as a bacteriocide and fungicide in cosmetics. Dichlorophene was reported to be used in a total of five cosmetic formulations at concentrations of 0% to 1.0%. Dichlorophen is used in the treatment of tapeworm infestation in man and animals and is the basis of a preparation against athlete’s foot. As a fungicide and bactericide it is recommended for the protection of textiles and materials including horticultural benches and equipment against moulds and algae.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL4685 Sources: http://www.ncbi.nlm.nih.gov/pubmed/20055453 |
70.0 µM [IC50] | ||
Target ID: G. lamblia growth Sources: http://www.ncbi.nlm.nih.gov/pubmed/3872626 |
|||
Target ID: T. vaginalis growth Sources: http://www.ncbi.nlm.nih.gov/pubmed/3872626 |
|||
Target ID: 2-propanol-supported respiration of Entamoeba histolytica Sources: http://www.ncbi.nlm.nih.gov/pubmed/6086381 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Curative | Unknown Approved UseUnknown |
|||
Curative | Unknown Approved UseUnknown |
|||
Curative | Unknown Approved UseUnknown |
|||
Curative | Unknown Approved UseUnknown |
|||
Curative | Mycota spray Approved UseFor the treatment and prevention of athletes foot. Launch Date2002 |
Doses
Dose | Population | Adverse events |
---|---|---|
1 % 1 times / day single, topical Studied dose Dose: 1 %, 1 times / day Route: topical Route: single Dose: 1 %, 1 times / day Sources: |
unhealthy, 29 years n = 1 Health Status: unhealthy Condition: itching lesions Age Group: 29 years Sex: F Population Size: 1 Sources: |
Other AEs: Contact dermatitis... |
360 g 1 times / day single, oral Studied dose Dose: 360 g, 1 times / day Route: oral Route: single Dose: 360 g, 1 times / day Sources: |
healthy, 59 years n = 1 Health Status: healthy Age Group: 59 years Sex: F Population Size: 1 Sources: |
Other AEs: Death... |
72 g 1 times / day single, oral Studied dose Dose: 72 g, 1 times / day Route: oral Route: single Dose: 72 g, 1 times / day Sources: |
unhealthy, 74 years n = 1 Health Status: unhealthy Condition: depression, chronic alcoholism, cardiac insufficiency and breast cancer Age Group: 74 years Sex: F Population Size: 1 Sources: |
Other AEs: Epigastric pain, Nausea... Other AEs: Epigastric pain Sources: Nausea Diarrhea Disturbance of liver function tests Injury to kidney Rhabdomyolysis |
AEs
AE | Significance | Dose | Population |
---|---|---|---|
Contact dermatitis | 1 % 1 times / day single, topical Studied dose Dose: 1 %, 1 times / day Route: topical Route: single Dose: 1 %, 1 times / day Sources: |
unhealthy, 29 years n = 1 Health Status: unhealthy Condition: itching lesions Age Group: 29 years Sex: F Population Size: 1 Sources: |
|
Death | 360 g 1 times / day single, oral Studied dose Dose: 360 g, 1 times / day Route: oral Route: single Dose: 360 g, 1 times / day Sources: |
healthy, 59 years n = 1 Health Status: healthy Age Group: 59 years Sex: F Population Size: 1 Sources: |
|
Diarrhea | 72 g 1 times / day single, oral Studied dose Dose: 72 g, 1 times / day Route: oral Route: single Dose: 72 g, 1 times / day Sources: |
unhealthy, 74 years n = 1 Health Status: unhealthy Condition: depression, chronic alcoholism, cardiac insufficiency and breast cancer Age Group: 74 years Sex: F Population Size: 1 Sources: |
|
Disturbance of liver function tests | 72 g 1 times / day single, oral Studied dose Dose: 72 g, 1 times / day Route: oral Route: single Dose: 72 g, 1 times / day Sources: |
unhealthy, 74 years n = 1 Health Status: unhealthy Condition: depression, chronic alcoholism, cardiac insufficiency and breast cancer Age Group: 74 years Sex: F Population Size: 1 Sources: |
|
Epigastric pain | 72 g 1 times / day single, oral Studied dose Dose: 72 g, 1 times / day Route: oral Route: single Dose: 72 g, 1 times / day Sources: |
unhealthy, 74 years n = 1 Health Status: unhealthy Condition: depression, chronic alcoholism, cardiac insufficiency and breast cancer Age Group: 74 years Sex: F Population Size: 1 Sources: |
|
Injury to kidney | 72 g 1 times / day single, oral Studied dose Dose: 72 g, 1 times / day Route: oral Route: single Dose: 72 g, 1 times / day Sources: |
unhealthy, 74 years n = 1 Health Status: unhealthy Condition: depression, chronic alcoholism, cardiac insufficiency and breast cancer Age Group: 74 years Sex: F Population Size: 1 Sources: |
|
Nausea | 72 g 1 times / day single, oral Studied dose Dose: 72 g, 1 times / day Route: oral Route: single Dose: 72 g, 1 times / day Sources: |
unhealthy, 74 years n = 1 Health Status: unhealthy Condition: depression, chronic alcoholism, cardiac insufficiency and breast cancer Age Group: 74 years Sex: F Population Size: 1 Sources: |
|
Rhabdomyolysis | 72 g 1 times / day single, oral Studied dose Dose: 72 g, 1 times / day Route: oral Route: single Dose: 72 g, 1 times / day Sources: |
unhealthy, 74 years n = 1 Health Status: unhealthy Condition: depression, chronic alcoholism, cardiac insufficiency and breast cancer Age Group: 74 years Sex: F Population Size: 1 Sources: |
PubMed
Title | Date | PubMed |
---|---|---|
Safety assessment of dichlorophene and chlorophene. | 2004 |
|
[Contact sensitization to pharmaceutic aids in dermatologic cosmetic and external use preparations]. | 2004 May |
|
Prediction of estrogen receptor agonists and characterization of associated molecular descriptors by statistical learning methods. | 2006 Nov |
|
Fate of organohalogens in US wastewater treatment plants and estimated chemical releases to soils nationwide from biosolids recycling. | 2009 Dec |
|
Profiles and some initial identifications of (anti)androgenic compounds in fish exposed to wastewater treatment works effluents. | 2010 Feb 1 |
|
Activity profiles of 309 ToxCast™ chemicals evaluated across 292 biochemical targets. | 2011 Mar 28 |
Patents
Sample Use Guides
In Vivo Use Guide
Curator's Comment: Can also be applied topically for treatment of Athlete’s Foot https://imedi.co.uk/mycota-spray
A dose of 5 g is given usually in the morning to treat cestode infections
Route of Administration:
Oral
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/3872626
0.93 mM dichlorophene killed T. vaginalis within 24 hours in Asami media, Trophozoites of G. lamblia and T. vaginalis were killed in shorter than 10 min with 0.074 mM dichlorophene in serum-free media.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
EPA PESTICIDE CODE |
55005
Created by
admin on Sat Dec 16 08:24:12 GMT 2023 , Edited by admin on Sat Dec 16 08:24:12 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID5041855
Created by
admin on Sat Dec 16 08:24:12 GMT 2023 , Edited by admin on Sat Dec 16 08:24:12 GMT 2023
|
PRIMARY | |||
|
10254-48-5
Created by
admin on Sat Dec 16 08:24:12 GMT 2023 , Edited by admin on Sat Dec 16 08:24:12 GMT 2023
|
NON-SPECIFIC STOICHIOMETRY | |||
|
89634
Created by
admin on Sat Dec 16 08:24:12 GMT 2023 , Edited by admin on Sat Dec 16 08:24:12 GMT 2023
|
PRIMARY | |||
|
6Y5TLW5O7J
Created by
admin on Sat Dec 16 08:24:12 GMT 2023 , Edited by admin on Sat Dec 16 08:24:12 GMT 2023
|
PRIMARY | |||
|
22232-25-3
Created by
admin on Sat Dec 16 08:24:12 GMT 2023 , Edited by admin on Sat Dec 16 08:24:12 GMT 2023
|
PRIMARY | |||
|
244-853-9
Created by
admin on Sat Dec 16 08:24:12 GMT 2023 , Edited by admin on Sat Dec 16 08:24:12 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD